State Street’s Design Therapeutics DSGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$7.02M Buy
659,575
+11,939
+2% +$121K ﹤0.01% 2795
2025
Q4
$6.07M Buy
647,636
+13,239
+2% +$104K ﹤0.01% 2899
2025
Q3
$4.78M Sell
634,397
-84,815
-12% -$425K ﹤0.01% 3008
2025
Q2
$2.42M Buy
719,212
+5,138
+0.7% +$19.2K ﹤0.01% 3243
2025
Q1
$2.76M Sell
714,074
-9,245
-1% -$44.1K ﹤0.01% 3126
2024
Q4
$4.46M Buy
723,319
+32,493
+5% +$188K ﹤0.01% 3023
2024
Q3
$3.72M Sell
690,826
-4,597
-0.7% -$21.6K ﹤0.01% 3095
2024
Q2
$2.33M Sell
695,423
-3,563
-0.5% -$13.9K ﹤0.01% 3262
2024
Q1
$2.82M Buy
698,986
+3,762
+0.5% +$10K ﹤0.01% 3166
2023
Q4
$1.84M Buy
695,224
+2,501
+0.4% +$5.73K ﹤0.01% 3337
2023
Q3
$1.63M Buy
692,723
+106,688
+18% +$498K ﹤0.01% 3405
2023
Q2
$3.69M Sell
586,035
-125,493
-18% -$768K ﹤0.01% 3148
2023
Q1
$4.11M Sell
711,528
-2,325,932
-77% -$17.4M ﹤0.01% 3066
2022
Q4
$31.2M Buy
3,037,460
+2,127,991
+234% +$28.8M ﹤0.01% 1936
2022
Q3
$15.2M Buy
909,469
+459,688
+102% +$9.15M ﹤0.01% 2428
2022
Q2
$6.3M Buy
449,781
+46,240
+11% +$625K ﹤0.01% 2980
2022
Q1
$6.52M Buy
403,541
+61,280
+18% +$939K ﹤0.01% 3044
2021
Q4
$7.33M Buy
342,261
+130,653
+62% +$2.24M ﹤0.01% 3062
2021
Q3
$3.11M Buy
211,608
+23,519
+13% +$391K ﹤0.01% 3484
2021
Q2
$3.74M Buy
+188,089
New +$4.75M ﹤0.01% 3375

Other funds holding DSGN